Brineura Intraventricular Injection 150mg, containing Cerliponase alpha (genetically recombined), is manufactured by BioMarin Pharmaceutical Japan. This injectable drug, with YJ code 3959422A1028 and standard 150mg 5mL x 1 bottle, is an enzyme replacement therapy that slows the loss of ambulation in pediatric patients with neuronal ceroid lipofuscinosis type 2 (CLN2) disease.
Brineura Intraventricular Injection 150mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →